Click Here For COVID-19 (Coronavirus) Studies

Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Jennifer Amengual, MD
Email
jea2149@cumc.columbia.edu

Dr. Amengual is an Assistant Professor of Medicine and Developmental Therapeutics. Her research goals are focused on developing targeted therapies for the treatment of lymphoma. As a physician-scientist, she aims to directly translate observations and concepts developed in the laboratory to patient care.


Clinical Studies Managed By Dr. Amengual:
More InfoTitleSponsorIRB Number
Details[CLOSED] Study for patients with newly diagnosed Mantle Cell Lymphoma using study drug (BTK Inhibitor)Janssen Research & Development LLCAAAL3027
DetailsStudy of Combinations of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Subjects with Hodgkin LymphomaNational Cancer Institute NCI NIH DHHSAAAS7604
DetailsStudy of FLX475 Alone and in Combination with Pembrolizumab in Advanced CancerFLX Bio, Inc.AAAS7290